Zobrazeno 1 - 10
of 1 390
pro vyhledávání: '"Mark WILCOX"'
Autor:
Maja Rupnik, Virginie Viprey, Sandra Janezic, Valerija Tkalec, Georgina Davis, Béatrice Sente, Nathalie Devos, Bruno H. Muller, Emmanuelle Santiago-Allexant, Philippe Cleuziat, Mark Wilcox, Kerrie Davies
Publikováno v:
Emerging Microbes and Infections, Vol 13, Iss 1 (2024)
Clostridioides difficile is a One Health pathogen found in humans, animals, and the environment, with food representing a potential transmission route. One Health studies are often limited to a single country or selected reservoirs and ribotypes. Thi
Externí odkaz:
https://doaj.org/article/98e87673e7a6493e80005fb92ab2586e
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Mark H. Wilcox
Publikováno v:
Future Microbiology. 11:991-994
Mark Wilcox speaks to Georgia Patey, Commissioning Editor: Professor Mark Wilcox is a Consultant Microbiologist and Head of Microbiology at the Leeds Teaching Hospitals (Leeds, UK), the Professor of Medical Microbiology at the University of Leeds (Le
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bd5d231377e786586aa5cbe64f3db3e5
https://doi.org/10.2217/fmb-2016-0123
https://doi.org/10.2217/fmb-2016-0123
Autor:
Wilcox M; Leeds Teaching Hospitals NHS Trust, Department of Microbiology, Old Medical School, LGI, Leeds, LS1 3EX.; University of Leeds, Leeds, LS2 9JT, UK.
Publikováno v:
Future microbiology [Future Microbiol] 2016 Aug; Vol. 11, pp. 991-4. Date of Electronic Publication: 2016 Aug 05.
Publikováno v:
International Journal of Infectious Diseases, Vol 124, Iss , Pp 118-123 (2022)
Recently, the recommendations for the treatment of Clostridioides difficile infection (CDI) have been updated. However, in addition to the clinical efficacy data, the drug of choice should ideally represent optimal antimicrobial stewardship, with an
Externí odkaz:
https://doaj.org/article/339c50fc5cc64bdcacc6d4cefc7bdc4b
Autor:
Matthew Dryden, Michal Kantecki, Jean Li Yan, Gregory G. Stone, Heidi Leister-Tebbe, Mark Wilcox
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 28, Iss , Pp 108-114 (2022)
ABSTRACT: Objectives: This exploratory pooled analysis assessed the efficacy and safety of ceftaroline fosamil and comparators across six phase III clinical trials in adults with community-acquired pneumonia (CAP) or complicated skin and soft-tissue
Externí odkaz:
https://doaj.org/article/9b91dfa17c6e4c0f8d6a9988707d2d8a
Autor:
Lucy Hocking, Mark Wilcox, Nicola Petrosillo, Paul Griffin, Theodore Steiner, Gail Attara, Joel Doré, Mark Cabling, Stephanie Stockwell, Robert J. Romanelli, Sonja Marjanovic
Publikováno v:
Frontiers in Medicine, Vol 9 (2023)
IntroductionArriving at a C. difficile infection (CDI) diagnosis, treating patients and dealing with recurrences is not straightforward, but a comprehensive and well-rounded understanding of what is needed to improve patient care is lacking. This man
Externí odkaz:
https://doaj.org/article/1d6c8cfebf4246aea4c7bef224fd1444
Publikováno v:
Clinical Infectious Diseases, 2005 Nov 01. 41(9), 1369-1369.
Externí odkaz:
https://www.jstor.org/stable/4463534
